The Rh and RhAG blood group systems

Immunohematology

Volumn 26, Issue 4, 2010, Pages 178-186

  Chou, Stella T ^a   Westhoff, Connie M ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; RHESUS ANTIGEN; RHESUS D ANTIBODY;

BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP SYSTEM; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HEREDITY; NOMENCLATURE; PRIORITY JOURNAL; REVIEW; SICKLE CELL;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, SICKLE CELL; BLOOD PROTEINS; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; PATHOLOGY, MOLECULAR; POLYMORPHISM, GENETIC; QUALITY IMPROVEMENT; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SEROLOGIC TESTS;

EID: 79955013437     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Levine P, Burnham L, Katzin WM, Vogel P. The role of isoimmunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol 1941;42: 925-37.
2. Freda VJ, Gorman JG, Pollack W. Rh factor: prevention of isoimmunization and clinical trial on mothers. Science 1966;151:828-30.
3. Mollison PL, Hughes-Jones NC, Lindsay M, Wessely J. Suppression of primary RH immunization by passively-administered antibody. Experiments in volunteers. Vox Sang 1969;16:421-39.
4. Race RR, Sanger R. Blood groups in man. 6th ed. Oxford, England: Blackwell, 1975.
5. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.
6. Le van Kim C, Mouro I, Chérif-Zahar B, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992;89:10925-9.
7. Chérif-Zahar B, Bloy C, Le Van Kim C, et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci U S A 1990;87:6243-7.
8. Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 1993;82: 651-5.
9. Simsek S, de Jong CA, Cuijpers HT, et al. Sequence analysis of cDNA derived from reticulocyte mRNAs coding for Rh polypeptides and demonstration of E/e and C/c polymorphisms. Vox Sang 1994;67:203-9.
10. Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8-16.
11. Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med 1940;43:223-4.
12. Tippett P. A speculative model for the Rh blood groups. Ann Hum Genet 1986;50:241-7.
13. Daniels G, Castilho L, Flegel WA, et al. International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang 2009;96:153-6.
14. Scott ML, Voak D, Liu W, Jones JW, Avent ND. Epitopes on Rh proteins. Vox Sang 2000;78(Suppl 2):117-20.
15. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78: 2747-52.
16. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-18.
17. Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.
18. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385-93.
19. Sun CF, Chou CS, Lai NC, Wang WT. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang 1998;75:52-7.
20. Daniels G. Human blood groups. 2nd ed. Cambridge, MA: Wiley-Blackwell, 2002.
21. Westhoff CM, Vege S, Nickle P, Hue-Roye K, Reid ME. A single nucleotide deletion in RHCE*cE responsible for the D- - haplotype in the Hispanic population. Vox Sang 2010:99 (Suppl):376.
22. Beckers EA, Porcelijn L, Ligthart P, et al. The RoHar antigenic complex is associated with a limited number of D epitopes and alloanti-D production: a study of three unrelated persons and their families. Transfusion 1996;36:104-8.
23. Wallace M, Lomas-Francis C, Tippett P. The D antigen characteristic of RoHar is a partial D antigen. Vox Sang 1996;70:169-72.
24. Flegel WA, Wagner FF, Chen Q, Schlanser G, Frame T, Westhoff CM, Moulds MK. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion 2006:46:1334-42.
25. Chen Q, Hustinx H, Flegel WA. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion 2006;46:766-72.
26. Wagner FF, Ladewig B, Flegel WA. The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids. Transfusion. 2003;43:1248-54.
27. Westhoff CM. Review: the Rh blood group D antigen... dominant, diverse, and difficult. Immunohematology 2005;21:155-63.
28. Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998;38:951-8.
29. Brumit MC, Carnahan GE, Stubbs JR, Storry JR, Reid ME. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype. Immunohematology 2002;18:40-2.
30. Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100:4223-31.
31. Reid ME, Storry JR, Issitt PD, et al. Rh haplotypes that make e but not hrB usually make VS. Vox Sang 1997;72:41-4.
32. Vege S, Westhoff CM. Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology 2006;22:143-7.
33. Issit P, Anstee, DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
34. Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology 2006;22:103-7.
35. Sesok-Pizzini DA, Friedman DF, Smith-Whitley K, Nance SJ. Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia. Immunohematology 2006;22:121-5.
36. Petz LD. Review: evaluation of patients with immune hemolysis. Immunohematology 2004;20:167-76.
37. Price TH, ed. Standards for blood banks and transfusion services. 26th ed. Bethesda, MD: AABB 2009:29.
38. Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554-60.
39. Yasuda H, Ohto H, Sakuma S, Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581-4.
40. Flegel WA, Khull SR, Wagner FF. Primary anti-D immunization by weak D type 2 RBCs. Transfusion 2000;40:428-34.
41. Mota M, Fonseca NL, Rodrigues A, Kutner JM, Castilho L. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang 2005;88:130-5.
42. Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983;23: 91-4.
43. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-92.
44. Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27: 94-8.
45. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-9.
46. Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007;47:736-47.
47. Hopp K, Weber K, Bellissimo D, Johnson ST, Pietz B. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010;50:40-6.
48. Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008;22: 117-32.
49. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
50. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-18.
51. Matassi G, Chérif-Zahar B, Raynal V, Rouger P, Cartron JP. Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family. Genomics 1998;47:286-93.
52. Tilley L, Green C, Poole J, et al. A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang 2010;98:151-9.
53. Gruswitz F, Chaudhary S, Ho JD, et al. Function of human Rh based on structure of RhCG at 2.1 A. Proc Natl Acad Sci U S A 2010;107:9638-43.